Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Strathdee, Steffanie A ^a   Lozada, Remedios ^b   Ojeda, Victoria D ^a   Pollini, Robin A ^a   Brouwer, Kimberly C ^a   Vera, Alicia ^a   Cornelius, Wayne ^c   Nguyen, Lucie ^a   Magis Rodriguez, Carlos ^d   Patterson, Thomas L ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pro COMUSIDA   (Mexico)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Centro Nacional para la Prevencion Y Control del VIH/SIDA e ITS   (Mexico)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDEMIC; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRATION; RISK ASSESSMENT; SAMPLING; SEX DIFFERENCE; STRUCTURED INTERVIEW; SYPHILIS; UNITED STATES; LEGAL ASPECT; MEXICO; POLICY; SUBSTANCE ABUSE;

ADULT; EMIGRATION AND IMMIGRATION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MEXICO; PUBLIC POLICY; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TRANSIENTS AND MIGRANTS; UNITED STATES;

EID: 50949124649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002690     Document Type: Article

References (55)

1. INEGI (2005) INEGI. XII Censo General de Población y Vivienda.
2. Bucardo J, Brouwer K, Magis-Rodriguez C, Ramos R, Fraga M, et al. (2005) Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend 79: 281-293.
3. Brouwer K, Case P, Ramos R, Magis-Rodriquez C, Bucardo J, et al. (2006) Trends in production, trafficking, and consumption of cocaine and methamphetamine in Mexico. Subst Use Misuse 41: 707-727.
4. Strathdee S, Fraga W, Case P, Firestone M, Brouwer K, et al. (2005) "Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health 82: iv58-73.
5. Patterson T, Semple S, Staines H, Lozada R, Orozovich P, Bucardo J (2008) Prevalence and correlates of HIV infection among female sex workers in two México-U.S. border cities. J Infect Dis 197(5): 728-32.
6. Secretaria de Salud (2007) Consejo Nacional para la Prevencion y Control del VIH/SIDA; Panorama epidemiologico del VIH/SIDA e ITS en México, 2007. Available at: http://www.salud.gob.mx/conasida/ estadis.htm (Accessed February 3, 2008).
7. Strathdee SA, Magis-Rodriguez C. Mexico's evolving HIV epidemic. JAMA, (in press).
8. del Rio C, Sepulveda J (2002) AIDS in Mexico: lessons learned and implications for developing countries. AIDS 16: 1445-1457.
9. Strathdee S, Philbin M, Semple S, Pu M, Orozovich P, et al. (2008) Correlates of injection drug use among female sex workers in two México-US border cities. Drug Alcohol Depend 1;92(1-3): 132-40.
10. Viani RM, Araneta MR, Ruiz-Calderon J, Hubbard P, Lopez G, et al. (2006) Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infecton. J Acquir Immune Defic Syndr 41: 87-92.
11. Brouwer K, Strathdee S, Magis-Rodriguez C, Bravo-Garcia E, Gavet C, et al. (2006) Estimated numbers of men and women infected with HIV/AIDS in Tijuana, México. J Urban Health 83: 299-307.
12. Strathdee S, Lozada R, Pollini R, Brouwer K, Mantsios A, et al. (2008) Individual, social and environmental influences associated with HIV infection among injection drug users in Tijuana, México. J Acquir Immune Defic Syndr 1;47(3): 369-76.
13. Frost S, Brouwer K, Firestone M, Ramos R, Ramos M, et al. (2006) Respondent-driven sampling of injecting drug users in two US-Mexico border cities: Recruitment networks and syphilis prevalence. J Urban Health 83 Suppl: 83-97.
14. Harvey E, Strathdee S, Patrick D, Ofner M, Archibald C, et al. (1998) A qualitative investigation into a HIV outbreak among injecton drug users in Vancouver. AIDS Care 1: 313-321.
15. Montgomery SB, Hyde J, De Rosa C, Rohrbach L, Ennett S, et al. (2002) Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse 28: 453-475.
16. Latkin CA, Hua W, Forman VL (2003) The relationship between social network characteristics and exchanging sex for drugs or money among drug users in Baltimore, MD, USA. Int J STD AIDS 14: 770-775.
17. Evans J, Hahn J, Page-Shafer K, Lum P, Stein E, Davidson P, et al. (2003) Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health 80: 137-146.
18. Heckathorn D (1997) Respondent driven sampling: a new approach to the study of hidden populations. Social Problems 44: 174-199.
19. Brouwer K, Lozada R, Cornelius W, Firestone-Cruz M, Strathdee S (In press) Deportation along the U.S.-Mexico border: its relation to drug use patterns and accessing care. Journal of Immigrant and Minority Health.
20. Magis-Rodriguez C, Brouwer K, Morales S (2005) HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs 37: 333-339.
21. Burnham K, Anderson D (2002) Model Selection and Multi-model Inference: A Practical-Theoretic Approach. Springer-Verlag. 2nd ed.
22. Fleming D, Wasserheit J (1999) From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75: 3-17.
23. Strathdee S, Galai N, Safaiean M, Celentano D, Vlahov D, et al. (2001) Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 161: 1281-1288.
24. Kral A, Bluthenthal R, Lorvick J, Gee L, Bacchetti P, et al. (2001) Sexual transmission of HIV-1 among injection drug users in San Francisco, USA; risk-factor analysis. Lancet 357: 1397-1401.
25. Spittal P, Craib K, Wood E, Laliberte N, Li K, et al. (2002) Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Cmaj 166: 894-899.
26. Montgomery SB, Hyde J, De Rosa C, Rohrbach L, Ennett S (2002) Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse 28: 453-475.
27. Ojeda V, Patterson T, Gonzales P, Strathdee S (in press) Contrasting beliefs and behaviors: Latinos' and immigrants' illicit drug use and the role of perceived risk and migration characteristics. Am J Publ Health.
28. Borges G, Medina-Mora M, Breslau J, Aguilar-Gaxiola S (2007) The effect of migration to the United States on substance use disorders among returned Mexican migrants and families of migrants. Am J Public Health 97: 1847-1851.
29. Grant B, Stinson F, Hasin D, Dawson D, Chou S, et al. (2004) Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61: 1226-1233.
30. Franzini L, Ribble J, Keddie A (2001) Understanding the Hispanic paradox. Ethn Dis 11: 496-518.
31. Hirsch J, Menese S, Thompson B, Negroni M, Pelcastre B, et al. (2007) The inevitability of infidelity: sexual reputation, social geographies, and marital HIV risk in rural Mexico. Am J Public Health 97: 986-996.
32. Cornelius W, Fitzgerald D, Borger S, eds (2008) Four Generations of Nortenos: New Research from the Cradle of Mexican Migration. Boulder, CO: Lynne Rienner Publishers
33. Cruz MF, Mantsios A, Ramos R, Case P, Brouwer KC, et al. (2007) A qualitative exploration of gender in the context of injection drug use in two US-Mexico border cities. AIDS Behav 11: 253-262.
34. Cornelius W, Fitzgerald D, Díaz-Hernández J, Borger S, eds (forthcoming) Oaxacalifornia. BoulderCO: Lynne Rienner Publishers.
35. SANDAG (2007) All Crossings at California's Ports of Entry. In: http://www.sandag.org/uploads/publicationid/publicationid_895_4055.pdf SDAoGAa, editor. San Diego: San Diego Association of Governments.
36. Nuñez-Neto B, García M (2007) Border security: the San Diego fence. Washington, DC: Congressional Research Service.
37. Suskolne V, Shtarkshall R (2002) Migration and HIV prevention programmes: linking structural factors, culture, and individual behaviour-an Israeli experience. Soc Sci Med 55: 1297-1307.
38. McMichael A (2004) Environmental and social influences on emerging infectious diseases: past, present and future. Philos Trans R Soc Lond B Biol Sci 359: 1049-1058.
39. Mayer J (2000) Geography, ecology and emerging infectious diseases. Soc Sci Med 50: 937-952.
40. Hawkes S, Hart G (1993) Travel, migration and HIV. AIDS Care 5: 207-214.
41. Aral S, Lipshutz J, Blanchard J (2007) Drivers of STD/HIV epidemiology and the timing and targets of STD/HIV prevention. Sex Transm Inf 83: 1-4.
42. Parrado E, Flippen C, McQuiston C (2004) Use of commercial sex workers among Hispanic migrants in North Carolina: implications for the spread of HIV. Perspcct Sex Reprod Health 36: 150-156.
43. Organista K, Carrillo H, Ayala G (2004) HIV prevention with Mexican migrants: review, critique, and recommendations. J Acquir Immune Defic Syndr 37: S227-239.
44. Lagarde E, Schim van der Loeff M, Enel C (2003) Mobility and the spread of human immunodeficiency virus into rural areas of West Africa. Int J Epidemiol 32: 744-752.
45. Deren, Kang SY, Rapkin B, Robles RR, Andia JF, et al. (2003) The utility of the PRECEDE model in predicting HIV risk behaviors among Puerto Rican injection drug users. AIDS Behav 7: 405-412.
46. Deren, Kang SY, Colon HM, Andia JF, Robles RR, et al. (2003) Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico. Am J Public Health 93: 812-816.
47. Ehrlich S, Tholandi M, Martinez S (2006) HIV Risk Assessment of Migrant Latino Day Laborers. http://wwwdhscagov/AIDS/Reports/PDF/2006/ 2679HIVRiskAssessMigrantLatinos0406pdf.
48. Paschane D, Fisher D (2000) Etiology of limited transmission diseases among drug users: does recent migration magnify the risk of sharing injection equipment? Soc Sci Med 50: 1091-1097.
49. Magis-Rodriguez C, Gayet C, Negroni M (2004) Migration and AIDS in Mexico: an overview based on recent evidence. J Acquir Immune Defic Syndr 37: S215-226.
50. Rhodes T, Mikhailova L, Sarang A, Lowndes C, Rylkov A, et al. (2003) Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med 57: 39-54.
51. Pollini R, Brouwer K, Lozada R, Ramos R, Cruz M, et al. (2008) Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction 103: 101-108.
52. Philbin M, Pollini R, Lozada R, Ramos R, Ramos M, et al. (in press) Correlates of shooting gallery attendance among drug injectors in Tijuana, Mexico: the role of the social environment. AIDS and Behav.
53. Grund J, Stern L, Kaplan C, Adriaans N, Drucker E (1992) Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. Br J Addict 87: 381-392.
54. Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG (1999) Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. Int J Drug Policy 10: 25-38.
55. Yearbook of Immigration Statistics, 2005 (2006) In: Security USDoH, editor. Washington, D.C: U.S. Government Printing Office.